ADAP
Adaptimmune Therapeutics plc American Depositary Shares (ADAP)
$60
About Adaptimmune Therapeutics plc American Depositary Shares (ADAP)
Adaptimmune Therapeutics Plc is commercial-stage cell therapy company, which focuses on providing novel cell therapies to people with cancer. Its clinical pipeline includes Afami-cel, Lete-cel, and ADP-A2M4CD8. The company was founded by Bent K. Jakobsen, James Julian Noble, and Helena Katrina Tayton-Martin in 2008 and is headquartered in Abingdon, the United Kingdom.
Details
Daily high
$0.60
Daily low
$0.59
Price at open
$0.60
52 Week High
$2.05
52 Week Low
$0.50
Market cap
154.8M
Dividend yield
0.00%
Volume
3.1M
Avg. volume
2.3M
P/E ratio
-2.81
Adaptimmune Therapeutics plc American Depositary Shares News
Details
Daily high
$0.60
Daily low
$0.59
Price at open
$0.60
52 Week High
$2.05
52 Week Low
$0.50
Market cap
154.8M
Dividend yield
0.00%
Volume
3.1M
Avg. volume
2.3M
P/E ratio
-2.81